MetLife Investment Advisors »

Corvus Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $237k 31k 7.70
2025-09-30 $248k 34k 7.37
2025-06-30 $128k 32k 4.00